CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for Khan et al., CA Cancer J Clin 30 (3) 189-190.
CA Cancer J Clin 1981; 31:78

© 1981 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

CA: A Cancer Journal for Clinicians, Vol 31, 78-78, Copyright © 1981 by American Cancer Society

Correction: Please Note

There was a typographical error in the dosage of actinomycin-D that appeared in "Case Report: Unexpected Favorable Outcome of Congenital Stage III Rhabdomyosarcoma" in the May/June 1980 issue of Ca (Vol 30, No 3, p 189). The correct dosage is 0.05 mg/kg/day i.v.x 5, not 0.5 mg.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by American Cancer Society.